华邦健康
(002004)
| 流通市值：79.00亿 | | | 总市值：82.96亿 |
| 流通股本：18.85亿 | | | 总股本：19.80亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 8,716,372,736.07 | 5,909,893,380.15 | 2,818,702,693.62 | 11,512,347,207.84 |
| 营业收入 | 8,716,372,736.07 | 5,909,893,380.15 | 2,818,702,693.62 | 11,512,347,207.84 |
| 二、营业总成本 | 7,642,682,670.49 | 5,226,417,168.19 | 2,516,630,644.28 | 10,357,705,761.77 |
| 营业成本 | 5,349,952,474.65 | 3,674,053,902.35 | 1,807,625,306.38 | 7,261,558,826.35 |
| 税金及附加 | 107,244,763.6 | 68,921,369.35 | 34,184,641.69 | 133,926,018.93 |
| 销售费用 | 865,170,392.36 | 625,123,463.32 | 270,091,149.77 | 1,127,296,200.71 |
| 管理费用 | 847,958,673.89 | 530,601,591.71 | 254,116,010.88 | 1,217,066,722.98 |
| 研发费用 | 249,121,408.99 | 177,165,564.38 | 76,271,189.09 | 341,616,761.85 |
| 财务费用 | 223,234,957 | 150,551,277.08 | 74,342,346.47 | 276,241,230.95 |
| 其中:利息费用 | 165,561,748.89 | 113,027,888.7 | 55,383,657.28 | 309,322,672.07 |
| 其中:利息收入 | 22,169,679.51 | 14,510,956.97 | 7,378,336.26 | 50,368,091.14 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -377,328.18 | -4,005,361.8 | -1,811,523.2 | 6,662,165.37 |
| 加:投资收益 | 31,507,698.11 | 65,499,509.42 | 19,368,252.16 | 60,323,670.48 |
| 资产处置收益 | 3,541,383.58 | 3,256,894.62 | 2,555,734.79 | 10,046,789.22 |
| 资产减值损失(新) | -23,430,274.65 | -20,943,279.88 | -3,944,680.78 | -185,872,182.51 |
| 信用减值损失(新) | -40,858,723.15 | -27,694,526.97 | -10,074,282.42 | -75,689,291.37 |
| 其他收益 | 39,865,244.25 | 26,274,760.3 | 13,754,360.92 | 76,473,226.67 |
| 四、营业利润 | 1,083,938,065.54 | 725,864,207.65 | 321,919,910.81 | 1,046,585,823.93 |
| 加:营业外收入 | 5,327,839.65 | 2,652,516.15 | 2,691,772.73 | 40,936,388.2 |
| 减:营业外支出 | 56,767,817.92 | 11,244,033.36 | 3,682,648.25 | 29,653,178.45 |
| 五、利润总额 | 1,032,498,087.27 | 717,272,690.44 | 320,929,035.29 | 1,057,869,033.68 |
| 减:所得税费用 | 278,713,259.52 | 190,189,642.6 | 80,016,403.95 | 176,635,761.25 |
| 六、净利润 | 753,784,827.75 | 527,083,047.84 | 240,912,631.34 | 881,233,272.43 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 753,784,827.75 | 527,083,047.84 | 240,912,631.34 | 881,233,272.43 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 470,917,184.87 | 319,346,014.86 | 154,832,474.27 | 713,188,344.47 |
| 少数股东损益 | 282,867,642.88 | 207,737,032.98 | 86,080,157.07 | 168,044,927.96 |
| 扣除非经常损益后的净利润 | 479,683,993.53 | 299,999,189.18 | 143,072,719.71 | 643,109,024.67 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.24 | 0.16 | 0.08 | 0.36 |
| (二)稀释每股收益 | 0.24 | 0.16 | 0.08 | 0.36 |
| 八、其他综合收益 | -50,301,506.65 | -35,506,741.85 | -13,450,188.44 | 19,220,275.54 |
| 归属于母公司股东的其他综合收益 | -22,817,314.47 | -16,415,003.58 | -6,257,657.32 | 15,429,559.73 |
| 九、综合收益总额 | 703,483,321.1 | 491,576,305.99 | 227,462,442.9 | 900,453,547.97 |
| 归属于母公司股东的综合收益总额 | 448,099,870.4 | 302,931,011.28 | 148,574,816.95 | 728,617,904.2 |
| 归属于少数股东的综合收益总额 | 255,383,450.7 | 188,645,294.71 | 78,887,625.95 | 171,835,643.77 |
| 公告日期 | 2026-10-26 | 2026-08-20 | 2026-04-25 | 2026-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |